AGAPE ATP CORPORATION Foreign Currency Transaction Gain (Loss), before Tax
AGAPE ATP CORPORATION (ATPC) reported Foreign Currency Transaction Gain (Loss), before Tax of $645.03 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-14
- AGAPE ATP CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $645.03K.
- AGAPE ATP CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $322.46K.
- AGAPE ATP CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $819.16K.
- AGAPE ATP CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $7.86K, a 211.29% increase year-over-year.
- AGAPE ATP CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2025 was $826.15K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $645.03K 10-Q · filed 2026-08-14 | $967.49K 10-Q · filed 2026-08-14 | $1.79M derived: sum of 3 quarters · filed 2026-08-14 | $1.79M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $322.46K 10-Q · filed 2026-05-15 | $1.14M derived: sum of 2 quarters · filed 2026-05-15 | $1.15M derived: sum of 3 quarters · filed 2026-05-15 | $1.15M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $819.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $827.02K derived: sum of 2 quarters · filed 2026-04-13 | $826.45K derived: sum of 3 quarters · filed 2026-08-14 | $826.15K 10-K · filed 2026-04-13 |
| 2025-09-30 | $7.86K 10-Q · filed 2025-11-13 | $7.29K derived: sum of 2 quarters · filed 2026-08-14 | $6.99K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$573.00 10-Q · filed 2026-08-14 | -$870.00 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$297.00 10-Q · filed 2026-05-15 | |||
| 2024-09-30 | $2.52K 10-Q · filed 2025-11-13 | $2.59K derived: sum of 2 quarters · filed 2025-11-13 | $1.75K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $62.00 10-Q · filed 2025-08-13 | -$780.00 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$842.00 10-Q · filed 2025-05-15 | |||
| 2023-09-30 | -$382.00 10-Q · filed 2024-11-14 | -$34.08K derived: sum of 2 quarters · filed 2024-11-14 | -$34.96K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$33.70K 10-Q · filed 2024-08-14 | -$34.58K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$876.00 10-Q · filed 2024-05-14 | |||
| 2022-09-30 | -$59.50K 10-Q · filed 2023-11-14 | -$126.92K derived: sum of 2 quarters · filed 2023-11-14 | -$143.39K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$67.42K 10-Q · filed 2023-08-14 | -$83.88K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$16.47K 10-Q · filed 2023-05-15 | |||
| 2021-09-30 | -$20.20K 10-Q · filed 2022-11-14 | -$94.03K 10-Q · filed 2022-11-14 | ||
| 2021-03-31 | -$72.13K 10-Q · filed 2022-05-13 | |||
| 2020-03-31 | -$74.62K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |